Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates from 7 Countries of South America and the Caribbean: 2010-2011

Sexually Transmitted Diseases

Volumn 44, Issue 3, 2017, Pages 157-160

  Thakur, Sidharath Dev ^a,b   Araya, Pamela ^c   Borthagaray, Graciela ^d   Galarza, Patricia ^e   Hernandez, Alina Llop ^f   Payares, Daisy ^g   Sanabria Cruz, Olga Marina ^h   Carvallo, Maria Elena Trigoso ⁱ   Corredor, Aura Helena ^b   Dillon, Jo Anne R ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

^d UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^e INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^f MINISTERIO DE SALUD PÚBLICA   (Cuba)

^g Instituto Nacional de Higiene Rafael Rangel   (Venezuela)

^h INSTITUTO NACIONAL DE SALUD   (Colombia)

ⁱ Centro Departmental de Vigilancia Information y Referencia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CARIBBEAN; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PENICILLIN RESISTANCE; SOUTH AMERICA; DRUG EFFECTS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CARIBBEAN REGION; CEFTRIAXONE; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLINS; SOUTH AMERICA; TETRACYCLINE;

EID: 85013288200     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000587     Document Type: Article

References (23)

1. Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 2015; 10:e0143304.
2. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae 2012. World Health Organization. Geneva, Switzerland.
3. Lewis DA. Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Curr Opin Infect Dis 2014; 27:62-67.
4. Dillon JR, Parti R, Thakur SD. Antibiotic resistance in Neisseria gonorrhoeae isolates: will infections be untreatable in the future? Cultures (Oxoid) 2015; 35:1-8.
5. Starnino S, Galarza P, CarvalloME, et al. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Sex Transm Dis 2012; 39:813-821.
6. Dillon JA, Trecker MA, Thakur SD. Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: challenges and opportunities. Sex Transm Infect 2013; 89(Suppl 4): iv36-iv41.
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: M100-S19. CLSI, Wayne, PA; 2009 edition.
8. Reyn A, BentzonMW, Thayer JD, et al. Results of comparative experiments using different methods for determining the sensitivity of Neisseria gonorrhoeae to penicillin G. Bull World Health Organ 1965; 32:477-502.
9. Australian Gonococcal Surveillance Programme. Use of a quality assurance scheme in a long-termmulti-centric study of antimicrobial susceptibility in Neisseria gonorrhoeae. Genitourin Med 1990; 66:8-13.
10. Centers ofDisease Control and Prevention. Gonococcal isolate surveillance project (GISP) protocol. Updated May 2016. Isolates with alert value MICs. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2016. Available at: https://www. cdc. gov/std/gisp/gisp-protocol-may-2016. pdf. AccessedMay June, 2016.
11. Martin I. Building a quality assurance program for the GASP network-an international collaboration. Sex Transm Dis 2014; 41:S29.
12. Gianecini R, Oviedo C, StafforiniG, et al. Neisseria gonorrhoeae resistant to ceftriaxone and cefixime, Argentina. Emerg Infect Dis 2016; 22:1139-1141.
13. Galarza PG, Alcalá B, Salcedo C, et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis 2009; 36:787-788.
14. Unemo M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015; 15:364.
15. Bignell CJ. BASHH guideline for gonorrhoea. Sex Transm Infect 2004; 80:330-331.
16. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56:332-336.
17. Uehara AA, Amorin EL, FerreiraMde F, et al. Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil. J Clin Microbiol 2011; 49:4208-4212.
18. Lahra MM, WHOWestern Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010. Commun Dis Intell Q Rep 2012; 36:95-100.
19. Cole MJ, Chisholm SA, Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010; 86:427-432.
20. Ctr Dis Control Prev. 2009. Sexually transmitted disease surveillance supplement. Gonococcal Isolate Surveillance Program (GISP). Annual report 2007. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. Available at: http://www. cdc. gov/ std/gisp2007/GISPSurvSupp2007Short. pdf. Accessed May 20, 2016.
21. Centers for Disease Control and Prevention. 2006. Sexually transmitted disease treatment guidelines 2006. MMWR Morb Mortal Wkly Rep 2006. 55(RR-11):1-94.
22. Boslego JW, Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinaseproducing Neisseria gonorrhoeae. N Engl J Med 1987; 317:272-278.
23. Ctr Dis Control Prev. Gonorrhea. Sexually transmitted diseases surveillance 2010. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. Available at http://www. cdc. gov/std/stats10/gonorrhea. html. Accessed on May 15, 2016.